Co-delivery of curcumin and Bcl-2 siRNA by PAMAM dendrimers for enhancement of the therapeutic efficacy in HeLa cancer cells

被引：99
|
作者：
Ghaffari, Maryam [1 ,2 ,3 ]
Dehghan, Gholamreza [2 ]
Baradaran, Behzad [4 ]
Zarebkohan, Amir [5 ]
Mansoori, Behzad [4 ]
Soleymani, Jafar [6 ]
Dolatabadi, Jafar Ezzati Nazhad [7 ]
Hamblin, Michael R. [8 ,9 ,10 ]
机构：
[1] Tabriz Univ Med Sci, Res Ctr Pharmaceut Nanotechnol, Tabriz, Iran
[2] Univ Tabriz, Fac Nat Sci, Dept Biol, Tabriz, Iran
[3] Tabriz Univ Med Sci, Student Res Comm, Tabriz, Iran
[4] Tabriz Univ Med Sci, Immunol Res Ctr, Tabriz, Iran
[5] Tabriz Univ Med Sci, Fac Adv Med Sci, Dept Med Nanotechnol, Tabriz, Iran
[6] Tabriz Univ Med Sci, Pharmaceut Anal Res Ctr, Tabriz, Iran
[7] Tabriz Univ Med Sci, Drug Appl Res Ctr, Tabriz, Iran
[8] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA
[9] Harvard Med Sch, Dept Dermatol, Boston, MA 02115 USA
[10] Univ Johannesburg, Fac Hlth Sci, Laser Res Ctr, ZA-2028 Doornfontein, South Africa
来源：
COLLOIDS AND SURFACES B-BIOINTERFACES | 2020年 / 188卷
关键词：
Curcumin; Bcl-2; siRNA; PAMAM dendrimer; Co-delivery; HeLa cancer cells; Nanoparticles; DENDROSOMAL CURCUMIN; ANTICANCER ACTIVITY; INDUCE APOPTOSIS; BREAST-CANCER; IN-VITRO; NANOPARTICLES; DRUG; DOXORUBICIN; CISPLATIN; PATHWAYS;
D O I：
10.1016/j.colsurfb.2019.110762
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
Co-delivery of therapeutic agents and small interfering RNA (siRNA) can be achieved by a suitable nanovehicle. In this work, the solubility and bioavailability of curcumin (Cur) were enhanced by entrapment in a poly-amidoamine (PAMAM) dendrimer, and a polyplex was formed by grafting Bcl-2 siRNA onto the surface amine groups to produce PAMAM-Cur/Bcl-2 siRNA nanoparticles (NPs). The synthesized polyplex NPs had a particle size of similar to 180 nm, and high Cur loading content of similar to 82 wt%. Moreover, the PAMAM-Cur/Bcl-2 siRNA NPs showed more effective cellular uptake, and higher inhibition of tumor cell proliferation compared to PAMAM-Cur nanoformulation and free Cur, due to the combined effect of co-delivery of Cur and Bcl-2 siRNA. The newly described PAMAM-Cur/Bcl-2 siRNA polyplex NPs could be a promising co-delivery nanovehicle.
引用
收藏
页数：11
相关论文
共 50 条
  • [1] Co-delivery of curcumin and Bcl-2 siRNA to enhance therapeutic effect against breast cancer cells using PEI-functionalized PLGA nanoparticles
    Sarpoli, Leila Mohammad Gholinia
    Zare-Karizi, Shohreh
    Heidari, Erfan
    Hasanzadeh, Akbar
    Bayandori, Mehrdad
    Azedi, Fereshteh
    Hamblin, Michael R.
    Karimi, Mahdi
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2022, 27 (07) : 785 - 793
  • [2] Co-delivery of Doxorubicin and Bcl-2 siRNA by Mesoporous Silica Nanoparticles Enhances the Efficacy of Chemotherapy in Multidrug-Resistant Cancer Cells
    Chen, Alex M.
    Zhang, Min
    Wei, Dongguang
    Stueber, Dirk
    Taratula, Oleh
    Minko, Tamara
    He, Huixin
    SMALL, 2009, 5 (23) : 2673 - 2677
  • [3] Targeted co-delivery nanosystem based on methotrexate, curcumin, and PAMAM dendrimer for improvement of the therapeutic efficacy in cervical cancer
    Aghanejad, Ayuob
    Kheiriabad, Shiva
    Ghaffari, Maryam
    Aghdash, Simin Namvar
    Ghafouri, Neda
    Dolatabadi, Jafar Ezzati Nazhad
    Andishmand, Hashem
    Hamblin, Michael R.
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [4] Polyethylenimine-Conjugated Hydroxyethyl Cellulose for Doxorubicin/Bcl-2 siRNA Co-Delivery Systems
    Park, Jiwon
    Kim, Seoyoung
    Kim, Tae-il
    PHARMACEUTICS, 2023, 15 (02)
  • [5] Multifunctional PAMAM Dendrimers Carrying SAHA, 5-FU, and a Therapeutic Gene for Targeted Co-Delivery Toward Colorectal Cancer Cells
    Bulkurcuoglu, Buenyamin
    Gurbuz, Mustafa Ulvi
    Tyciakova, Silvia
    Pavlov, Kristina
    Mojzesova, Nikoleta
    Matuskova, Miroslava
    Tulu, Metin
    Ercelen, Sebnem
    BIOTECHNOLOGY JOURNAL, 2024, 19 (11)
  • [6] Co-delivery of Bcl-2 siRNA and doxorubicin through gold nanoparticle-based delivery system for a combined cancer therapy approach
    Tunc, Cansu Umran
    Aydin, Omer
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2022, 74
  • [7] Synergistic anticancer effects of co-delivery of linc-RoR siRNA and curcumin using polyamidoamine dendrimers against breast cancer
    Vahedi, Farzaneh
    Javan, Bita
    Sharbatkhari, Mahrokh
    Soltani, Alireza
    Shafiee, Mohammad
    Memarian, Ali
    Erfani-Moghadam, Vahid
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2024, 705
  • [8] Co-Delivery of siRNA and Docetaxel to Cancer Cells by NLC for Therapy
    Senel, Behiye
    Basaran, Ebru
    Akyil, Evrim
    Guven, Umay Merve
    Buyukkoroglu, Gulay
    ACS OMEGA, 2024, 9 (10): : 11671 - 11685
  • [9] Inhibition of cell proliferation through an ATP-responsive co-delivery system of doxorubicin and Bcl-2 siRNA
    Zhang, Jianxu
    Wang, Yudi
    Chen, Jiawen
    Liang, Xiao
    Han, Haobo
    Yang, Yan
    Li, Quanshun
    Wang, Yanbo
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2017, 12 : 4721 - 4732
  • [10] Co-delivery of Bcl-2 siRNA and doxorubicin using liposome-incorporated poly(ε-caprolactone) /chitosan nanofibers for the treatment of lung cancer
    Kordbacheh, Hananeh
    Bahmani, Ehsan
    Bybordi, Sara
    Rezaee, Aryan
    Dehghanian, Zahra
    Ehsanfar, Niloufar
    Goleij, Pouya
    Sharifianjazi, Fariborz
    Irani, Mohammad
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2024, 99
12345